WAL 801 CL dry syrup placebo

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Dermatitis, AtopicRhinitis, Allergic, Perennial

Phase 3

WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic Rhinitis

CompletedNCT02182544

Boehringer IngelheimRhinitis, Allergic, Perennial

Start: 2001-06-30Updated: 2014-07-14

WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis Patients

CompletedNCT02182557

Boehringer IngelheimDermatitis, Atopic

Start: 2001-06-30Updated: 2014-07-14